Rationale for the use of alpha-blockers in the treatment of benign prostatic hyperplasia (BPH).
Kawabe
K
K
Department of Urology, Faculty of Medicine, University of Tokyo, Japan.
Moriyama
N
N
Yamada
S
S
Taniguchi
N
N
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists